gefitinib has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agouni, A; Akhtar, S; Alanazi, FE; Aldhfyan, A; Alhoshani, A; Alotaibi, MR; Attwa, MW; Hourani, S; Kadi, AA; Korashy, HM; Zeidan, A | 1 |
| Ahmad, SF; Al-Alallah, IA; Alhaider, AA; Anazi, FE; Ansari, MA; Assiri, MA; Attafi, IM; Belali, OM; Korashy, HM | 1 |
2 other study(ies) available for gefitinib and Cardiotoxicity
| Article | Year |
|---|---|
EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation:
Topics: Animals; Antineoplastic Agents; Cardiotoxicity; Cell Line; ErbB Receptors; Forkhead Box Protein O3; Gefitinib; Male; Membrane Potential, Mitochondrial; Microsomes; Myocardium; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cardiomegaly; Cardiotoxicity; Caspase 3; Cell Line; Dose-Response Relationship, Drug; Gefitinib; Gene Expression Regulation; Heme Oxygenase (Decyclizing); Male; Myocytes, Cardiac; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |